Melissa Hadley Barrett explains SPONTAN® real-world data
At the Asia-Pacific Prostate Cancer Conference (APCC) in Melbourne, Nurse Practitioner and Sexologist Melissa Hadley Barrett presented outcomes from 147 men who used SPONTAN® nasal spray with a 93% response among men seeking greater convenience and spontaneity. The retrospective study included 147 treatment-experienced men prescribed SPONTAN® in routine Australian clinical practice, making it the largest real-world dataset reported for SPONTAN to date.
Suggested videos

LTP | Clinical and Commercial Webinar
LTR Pharma · 38:01

LTR Pharma's US Launch Plan for ROXAS Could Be a Big Step
Small Caps · 6:24

LTR Pharma (LTP) REALITY SHOCK: This Isn’t a Biotech Game — It’s a Revolution
WallStreetPulse01 · 10:21

Lee Rodne, CEO of LTR Pharma, Discusses His Company's New Nasal Spray Formulation for ED
Synthetic dot com - All Things Biotech · 28:49

LTR secures first US commercial deal for ROXUS
Stockhead · 1:23

LTR Pharma (ASX:LTP) funded with the FDA in its sights
Ausbiz Capital · 6:58

Pearls & Perspectives: Expanding Options for Men With Erectile Dysfunction, With Tom Riester
Urology Times · 9:34